| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |